GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Syneron Medical Ltd (NAS:ELOS) » Definitions » Intangible Assets

Syneron Medical (Syneron Medical) Intangible Assets : $25.9 Mil (As of Mar. 2017)


View and export this data going back to 2004. Start your Free Trial

What is Syneron Medical Intangible Assets?

Intangible assets are defined as identifiable non-monetary assets that cannot be seen, touched or physically measured. Syneron Medical's intangible assets for the quarter that ended in Mar. 2017 was $25.9 Mil.


Syneron Medical Intangible Assets Historical Data

The historical data trend for Syneron Medical's Intangible Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syneron Medical Intangible Assets Chart

Syneron Medical Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Intangible Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 55.65 42.42 46.98 34.14 26.77

Syneron Medical Quarterly Data
Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17
Intangible Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 33.11 28.76 27.70 26.77 25.91

Syneron Medical Intangible Assets Calculation

Intangible assets are defined as identifiable non-monetary assets that cannot be seen, touched or physically measured. Examples of intangible assets include trade secrets, copyrights, patents, trademarks. If a company acquires assets at the prices above the book value, it may carry goodwill on its balance sheet. Goodwill reflects the difference between the price the company paid and the book value of the assets.


Syneron Medical  (NAS:ELOS) Intangible Assets Explanation

If a company (company A) received a patent through their own work, though it has value, it does not show up on its balance sheet as an intangible asset. However, if company A sells this patent to company B, it will show up on company B's balance sheet as an intangible asset.

The same applies to brand names, trade secrets etc. For instance, Coca-Cola's brand is extremely valuable, but the brand does not appear on its balance sheet, because the brand was never acquired.

Some intangibles are amortized. Amortization is the depreciation of intangible assets.

Many intangibles are not amortized. They may still be written down when the company decides the asset is impaired.

Whenever you see an increase in goodwill over a number of years, you can assume it's because the company is out buying other businesses above book value. GOOD if buying businesses with durable competitive advantage.

If goodwill stays the same, the company when acquiring other companies is either paying less than book value or not acquiring. Businesses with moats never sell for less than book value.

Intangibles acquired are on balance sheet at fair value.

Internally developed brand names (Coke, Wrigleys, Band-Aid) however are not reflected on the balance sheet.

One of the reasons competitive advantage power can remain hidden for so long.


Be Aware

Companies may change the way intangible assets are amortized, and this will affect their reported earnings.


Syneron Medical Intangible Assets Related Terms

Thank you for viewing the detailed overview of Syneron Medical's Intangible Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Syneron Medical (Syneron Medical) Business Description

Traded in Other Exchanges
N/A
Address
Syneron Medical Ltd., was incorporated in the State of Israel in July 2000. The Company completed its initial public offering of ordinary shares in August 2004. It designs, develops and markets aesthetic medical products based on its various technologies including its proprietary Electro-Optical Synergy, or ELOS, technology, which uses the synergy between electrical energy, including radiofrequency or RF energy, and optical energy to provide effective, safe and affordable aesthetic medical treatments. The Company's products, which it sells mainly to physicians and other practitioners, target non-invasive aesthetic medical procedures, including hair removal, wrinkle reduction, rejuvenation of the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, acne treatment, treatment of leg veins, treatment for the temporary reduction in the appearance of cellulite and thigh circumference, ablation and resurfacing of the skin and laser-assisted lipolysis and topical skin brightening products.
Executives
North Tide Capital, Llc 10 percent owner 500 BOYLSTON STREET, SUITE 1860, BOSTON MA 02116
Laughlin Conan director, 10 percent owner C/O NORTH TIDE CAPITAL, LLC, 500 BOYLSTON STREET, SUITE 1860, BOSTON MA 02116
North Tide Capital Master, Lp 10 percent owner C/O NORTH TIDE CAPITAL, LLC, 500 BOYLSTON STREET, SUITE 1860, BOSTON MA 02116

Syneron Medical (Syneron Medical) Headlines